Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:04:22 EDT Mon 06 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:ATRA
- ATARA BIOTHERAPEUTICS INC -
Website unknown - click to update
04:04:22 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
ATRA
- Q
0.1
0.66
·
0.6944
0.3
0.67
+0.0197
3.0
741.8
387
2,042
0.6501
0.6849
0.65
3.015 0.1986
May 03
May 03
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Financial Status:
Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 2042
More trades...
Time ET
Ex
Price
Change
Volume
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-03 16:01
U:ATRA
News Release
200
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-04-05 16:01
U:ATRA
News Release
200
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-03-28 08:30
U:ATRA
News Release
200
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
2024-02-29 09:05
U:ATRA
News Release
200
Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
2024-02-28 16:30
U:ATRA
News Release
200
Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference
2024-02-14 09:00
U:ATRA
News Release
200
Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis
2024-01-31 18:30
U:ATRA
News Release
200
Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel ‚ ® Data in The Lancet Oncology
2024-01-08 09:00
U:ATRA
News Release
200
Atara Biotherapeutics Announces $15 Million Registered Direct Offering
2024-01-08 08:00
U:ATRA
News Release
200
Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-04 16:01
U:ATRA
News Release
200
Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-20 16:01
U:ATRA
News Release
200
Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel ‚ ® Partnership with Pierre Fabre Laboratories
2023-12-11 12:00
U:ATRA
News Release
200
Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting
2023-12-01 16:01
U:ATRA
News Release
200
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-11-29 18:05
U:ATRA
News Release
200
Atara Biotherapeutics To Present Positive New Tab-cel ‚ ® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023
2023-11-22 16:01
U:ATRA
News Release
200
Atara Biotherapeutics to Participate at the 6th Annual Evercore ISI HealthCONx Conference
2023-11-10 16:01
U:ATRA
News Release
200
Atara Biotherapeutics To Participate at the Stifel Healthcare Conference
2023-11-08 17:35
U:ATRA
News Release
200
Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis
2023-11-01 08:30
U:ATRA
News Release
200
Atara Biotherapeutics Announces Expanded Global Tab-cel ‚ ® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results
2023-10-06 16:01
U:ATRA
News Release
200
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-09-19 16:01
U:ATRA
News Release
200
Atara Biotherapeutics Announces Plans to Submit Tab-cel ‚ ® BLA in Q2 2024 Following FDA Agreement on Comparability